Incidence of hematological toxicity with use of immunotherapy and chemotherapy in advanced non-small cell lung cancer

Incidence of hematological toxicity with use of immunotherapy and chemotherapy in advanced non-small cell lung cancer

Saved in:

Bibliographic Details
Main Authors:	Wenhai Fu, Yu Jiang, Wenjun Ye, Ran Zhong, Shan Xiong, Jianfu Li, Caichen Li, Jianxing He, Wenhua Liang, Xiangxiang Pan
Format:	Article
Language:	English
Published:	Wolters Kluwer 2025-01-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000003298
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Behavior of Anemia due to Toxicity to Chemotherapy in Patients with Lung Cancer
by: Mahité Cañete Fonseca, et al.
Published: (2023-08-01)

Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer
by: Huiping Qiang, et al.
Published: (2025-03-01)

Transcriptional regulatory network analysis identifies GRN as a key regulator bridging chemotherapy and immunotherapy response in small cell lung cancer
by: Seungyeul Yoo, et al.
Published: (2025-02-01)

Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy
by: Dongyan Shi, et al.
Published: (2023-01-01)

Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies
by: Shangjun Sun, et al.
Published: (2018-01-01)

Chemotherapy and radiotherapy’s toxicity prediction in the surgical cancer patient
by: Juan Carlos Arranz Pozo, et al.
Published: (2023-10-01)

Recent global patterns in skin cancer incidence, mortality, and prevalence
by: Mingyue Wang, et al.
Published: (2025-01-01)

Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy
by: Yufan CHEN, et al.
Published: (2025-01-01)

Advancements in cellular immunotherapy: overcoming resistance in lung and colorectal cancer
by: Lijuan Qin, et al.
Published: (2025-02-01)

Daratumumab improves the hematological response and kidney function of patients with light chain deposition disease
by: Xin Zhang, et al.
Published: (2025-01-01)

Retracted: The Combined Clinical Efficacy and Safety Analysis of Adoptive Immunotherapy with Radiotherapy and Chemotherapy in Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis
by: Applied Bionics and Biomechanics
Published: (2023-01-01)

Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma
by: Kai Huang
Published: (2025-01-01)

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
by: Carmine Carbone, et al.
Published: (2019-01-01)

Ginseng polysaccharides circumvent acquired resistance to anti-PD-1 immunotherapy in patients with non-small cell lung cancer
by: Jumin Huang, et al.
Published: (2025-02-01)

Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies
by: Bobbak Vahid, et al.
Published: (2008-01-01)

Consequences of Hyperoxia and the Toxicity of Oxygen in the Lung
by: William J. Mach, et al.
Published: (2011-01-01)

Subacute toxicity of isoliquiritigenin-zein phosphatidylcholine nanoparticles on biochemical, hematological, and histopathological parameters in Sprague-Dawley rats
by: Ke Yang, et al.
Published: (2024-04-01)

Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis
by: Peijun Tang, et al.
Published: (2022-01-01)

Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy
by: Dewen Zhan, et al.
Published: (2025-01-01)

Hyperthermic intraperitoneal chemotherapy (HIPEC) increases risk of local anesthetic systemic toxicity (LAST)
by: Masahiko Tsuchiya, et al.
Published: (2025-01-01)

The Financial Toxicity Experience of Patients with Colorectal Cancer During Chemotherapy: A Qualitative Study
by: Yanli Yao, et al.
Published: (2024-12-01)

Inflammatory burden index as a prognostic marker in patients with advanced gastric cancer treated with neoadjuvant chemotherapy and immunotherapy
by: Jiao-Bao Huang, et al.
Published: (2025-01-01)

Development of physical technology plays an important role in reducing radiation-induced lung injury
by: Han Bai, et al.
Published: (2025-02-01)

Pediatric Hematology : Oncology Secrets /
by: Weiner, Michael A.
Published: (2002)

Does Intraperitoneal Chemotherapy Increase the Incidence of Anastomotic Leakage after Colorectal Cancer Surgery: A Systematic Review and Meta-Analysis
by: Yu Yang, et al.
Published: (2021-01-01)

The prognosis and metabolite changes of NSCLC patients receiving first‐line immunotherapy combined chemotherapy in different M1c categories according to 9th edition of TNM classification
by: Liang Zheng, et al.
Published: (2024-09-01)

Risk Stratification and Adjuvant Chemotherapy for High‐Risk Stage IA Lung Adenocarcinoma: The Unmet Needs
by: Chen Shen, et al.
Published: (2025-01-01)

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for stage II–IVa esophageal cancer: a network meta-analysis
by: Mingxing Wang, et al.
Published: (2025-01-01)

Complete Disappearance of Choroidal Metastasis from Lung Adenocarcinoma Treated with Bevacizumab and Chemotherapy
by: Hampig Raphael Kourie, et al.
Published: (2015-01-01)

Hyperthermic intraperitoneal chemotherapy: Ideal and reality
by: Fan-He Dong, et al.
Published: (2025-02-01)

Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues
by: Pengliang Xu, et al.
Published: (2025-02-01)

Combination of ataxia telangiectasia and Rad3-related inhibition with ablative radiotherapy remodels the tumor microenvironment and enhances immunotherapy response in lung cancer
by: Jenny Ling-Yu Chen, et al.
Published: (2024-11-01)

Efficacy and Safety of Anlotinib and PD-1/L1 Inhibitors as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer Patients who Have Achieved Stable-Disease After First-Line Treatment with Chemotherapy and Immunotherapy: A Retrospective Study
by: Yi Peng MD, et al.
Published: (2025-01-01)

Neoadjuvant programmed death ligand-1 with chemotherapy versus chemotherapy alone for limited-stage small-cell lung cancer: a retrospective study
by: Zhi Yang, et al.
Published: (2025-01-01)

Wintrobe's Clinical Hematology: volume 2 /
by: Bithell, Thomas C.
Published: (1993)

The Role of Immunotherapy in Extensive Stage Small-Cell Lung Cancer: A Review of the Literature
by: Ioanna Tsiouprou, et al.
Published: (2019-01-01)

Predictive value of dendritic cell-related genes for prognosis and immunotherapy response in lung adenocarcinoma
by: Zihao Sun, et al.
Published: (2025-01-01)

Hematological manifestations of autoimmune gastritis
by: Ye. A. Losik, et al.
Published: (2016-08-01)

Zygomycosis in Two Hematologic Cases
by: M. T. García-Romero, et al.
Published: (2011-01-01)

Abnormal Hematological Indices in Cirrhosis
by: Amir A Qamar, et al.
Published: (2009-01-01)